1

Mini-antibodies Reactivate tumor suppressor p53: A New Pathway for Cancer Treatment

News Discuss 
A major advance in cancer study is occurring with the use of VHH fragments to reactivate mutated p53. This vital tumor suppressor protein is frequently disabled in many forms of malignancies, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story